JP2022529065A5 - - Google Patents
Info
- Publication number
- JP2022529065A5 JP2022529065A5 JP2021561943A JP2021561943A JP2022529065A5 JP 2022529065 A5 JP2022529065 A5 JP 2022529065A5 JP 2021561943 A JP2021561943 A JP 2021561943A JP 2021561943 A JP2021561943 A JP 2021561943A JP 2022529065 A5 JP2022529065 A5 JP 2022529065A5
- Authority
- JP
- Japan
- Prior art keywords
- ttd
- sequence
- domain
- nucleic acid
- rich
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025077741A JP2025121988A (ja) | 2019-04-17 | 2025-05-08 | 効率的なrnaトランススプライシングのための三重らせんターミネータ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962835164P | 2019-04-17 | 2019-04-17 | |
| US62/835,164 | 2019-04-17 | ||
| PCT/US2020/028797 WO2020214973A1 (en) | 2019-04-17 | 2020-04-17 | Triple helix terminator for efficient rna trans-splicing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025077741A Division JP2025121988A (ja) | 2019-04-17 | 2025-05-08 | 効率的なrnaトランススプライシングのための三重らせんターミネータ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022529065A JP2022529065A (ja) | 2022-06-16 |
| JP2022529065A5 true JP2022529065A5 (enExample) | 2023-04-25 |
Family
ID=72837942
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021561943A Pending JP2022529065A (ja) | 2019-04-17 | 2020-04-17 | 効率的なrnaトランススプライシングのための三重らせんターミネータ |
| JP2025077741A Pending JP2025121988A (ja) | 2019-04-17 | 2025-05-08 | 効率的なrnaトランススプライシングのための三重らせんターミネータ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025077741A Pending JP2025121988A (ja) | 2019-04-17 | 2025-05-08 | 効率的なrnaトランススプライシングのための三重らせんターミネータ |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220204989A1 (enExample) |
| EP (1) | EP3956442A4 (enExample) |
| JP (2) | JP2022529065A (enExample) |
| KR (1) | KR20220002910A (enExample) |
| CN (1) | CN114040974B (enExample) |
| BR (1) | BR112021020539A2 (enExample) |
| CA (1) | CA3133555A1 (enExample) |
| IL (1) | IL287243A (enExample) |
| MX (1) | MX2021012702A (enExample) |
| WO (1) | WO2020214973A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020010959A (es) | 2018-04-17 | 2021-01-15 | Univ Pennsylvania | Moleculas de empalme trans. |
| CN114040974B (zh) * | 2019-04-17 | 2025-11-04 | 宾夕法尼亚州大学信托人 | 用于高效rna反式剪接的三螺旋终止子 |
| AU2022259416A1 (en) * | 2021-04-15 | 2023-11-16 | Tacit Therapeutics, Inc. | High efficiency trans-splicing for replacement of targeted rna sequences in human cells |
| IL311101A (en) | 2021-09-03 | 2024-04-01 | Tacit Therapeutics Inc | RNA editing through recruitment of SPLICEOSOME components |
| WO2023205694A2 (en) * | 2022-04-20 | 2023-10-26 | Tacit Therapeutics, Inc. | Stabilization of therapeutic trans-splicing rna molecules in human cells |
| US20250290067A1 (en) * | 2022-05-03 | 2025-09-18 | Tacit Therapeutics, Inc. | Localization of trans-splicing nucleic acid molecules to and within the cellular nucleus |
| IL316944A (en) * | 2022-05-13 | 2025-01-01 | Ascidian Therapeutics Inc | ABCA4 cross-linking molecules |
| EP4622662A1 (en) | 2022-11-23 | 2025-10-01 | Amber Bio Inc. | Gene-modifying endonucleases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2151248A1 (en) * | 2008-07-30 | 2010-02-10 | Johann Bauer | Improved pre-mRNA trans-splicing molecule (RTM) molecules and their uses |
| CN104955951A (zh) * | 2012-10-16 | 2015-09-30 | 麻省理工学院 | 稳定的非多腺苷酸化rna的产生 |
| GB201219762D0 (en) * | 2012-11-02 | 2012-12-19 | Bauer Johann | A RNA trans-splicing molecule (RTM) for use in the treatment of cancer |
| EP2986635B1 (en) * | 2013-04-18 | 2018-10-03 | Fondazione Telethon | Effective delivery of large genes by dual aav vectors |
| AU2016355343C1 (en) * | 2015-11-19 | 2024-10-03 | Lloyd G. Mitchell | Compositions and methods for correction of heritable ocular disease |
| WO2019027869A1 (en) * | 2017-07-31 | 2019-02-07 | Massachusetts Institute Of Technology | RNA-CLUSTER INDUCED TRANSCRIPT STABILIZER AND USES THEREOF |
| MX2020010959A (es) * | 2018-04-17 | 2021-01-15 | Univ Pennsylvania | Moleculas de empalme trans. |
| CN114040974B (zh) * | 2019-04-17 | 2025-11-04 | 宾夕法尼亚州大学信托人 | 用于高效rna反式剪接的三螺旋终止子 |
-
2020
- 2020-04-17 CN CN202080044745.1A patent/CN114040974B/zh active Active
- 2020-04-17 WO PCT/US2020/028797 patent/WO2020214973A1/en not_active Ceased
- 2020-04-17 CA CA3133555A patent/CA3133555A1/en active Pending
- 2020-04-17 MX MX2021012702A patent/MX2021012702A/es unknown
- 2020-04-17 US US17/604,228 patent/US20220204989A1/en active Pending
- 2020-04-17 BR BR112021020539A patent/BR112021020539A2/pt unknown
- 2020-04-17 JP JP2021561943A patent/JP2022529065A/ja active Pending
- 2020-04-17 KR KR1020217034092A patent/KR20220002910A/ko active Pending
- 2020-04-17 EP EP20791307.0A patent/EP3956442A4/en active Pending
-
2021
- 2021-10-13 IL IL287243A patent/IL287243A/en unknown
-
2025
- 2025-05-08 JP JP2025077741A patent/JP2025121988A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12472239B2 (en) | Guide RNA for repairing a mutant human titin gene using CRISPR technology | |
| US12252703B2 (en) | Closed-ended linear duplex DNA for non-viral gene transfer | |
| JP7478923B2 (ja) | シュードウリジン化のための核酸分子 | |
| WO2023154693A1 (en) | Aav capsid variants and uses thereof | |
| JP2009537129A (ja) | エキソンスキッピングを誘発する為の手段及び方法 | |
| WO2015157070A2 (en) | Crispr/cas-related methods and compositions for treating cystic fibrosis | |
| JP7481755B2 (ja) | 組換えパルボウイルスベクターならびにその作製および使用方法 | |
| US20250215453A1 (en) | Aav capsid variants and uses thereof | |
| EP3793566A1 (en) | Compositions and methods for reducing spliceopathy and treating rna dominance disorders | |
| JP2025121988A (ja) | 効率的なrnaトランススプライシングのための三重らせんターミネータ | |
| JP2024107295A5 (enExample) | ||
| CN119137273A (zh) | 包括工程化核内小RNA(snRNA)的组合物和方法 | |
| JP2021520837A5 (enExample) | ||
| JP2024504608A (ja) | 遺伝子操作rnaを使用した内因性adarの活用による標的化rnaの編集 | |
| JP2022553573A5 (enExample) | ||
| US20250388626A1 (en) | Aav capsid variants and uses thereof | |
| WO2025038430A1 (en) | Aav capsid variants and uses thereof | |
| WO2018139637A1 (ja) | 核酸封入aav中空粒子 | |
| CN117980482A (zh) | Rbm20突变的基因组编辑 | |
| CN1286980C (zh) | 表达人类反义受磷蛋白基因的重组腺相关病毒及其制备方法 | |
| WO2026090560A1 (en) | Engineered nucleic acids and uses thereof | |
| TW202409289A (zh) | 用於治療肌強直性營養不良之組合物及方法 | |
| CN121263523A (zh) | 核酸关闭开关及其方法和用途 | |
| HK40069282A (en) | Closed-ended linear duplex dna for non-viral gene transfer | |
| HK40002860B (en) | Closed-ended linear duplex dna for non-viral gene transfer |